Delivery Order SPE2DB25D3306-SPE2DB25FUCMA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,012.85 to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine-Codeine 50-300mg tablets (100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,043.53 firm fixed price delivery order to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (100 count) on July 28, 2025, with completion scheduled for July 29, 2025. This competitive award, issued without set-aside designation, is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $1,258.58 delivery order to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) on July 31, 2025, with completion expected by August 1, 2025. This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $4,394.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically Butalbital-Acetaminophen-Caffeine-Codeine 50-300mg in 100-count units. This non-set-aside contract was awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $9,373.17 to AmerisourceBergen Drug Corp for butalbital-acetaminophen-caffeine 50-325-40mg tablets (100 count) on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-set-aside, competitively awarded contract was issued under firm fixed-price terms and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The product being supplied is a combination pharmaceutical...
- The Defense Logistics Agency awarded a $4,242.27 delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (100 count). This firm fixed price delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets in quantities of 100 units. This is a competitively awarded, firm fixed price contract with no set-aside designation, valued at $1,474.20 and scheduled for completion by August 29, 2025. The product will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets in quantities of 100 units, with a contract ceiling value of $1,228.50. This delivery order represents a firm fixed-price transaction with no set-aside designation, indicating competitive award. The contract is classified as a child action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,714.19 to AmerisourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) with a firm fixed price and completion date of August 27, 2025. This non-set-aside competitive award was made to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,516.31 to AmerisourceBergen Drug Corp for Butalbital-Aspirin-Caffeine tablets (90-count) on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the company's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, serves as a prime...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCMADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for butalbital-acetaminophen-caffeine with codeine (50-300mg, 100 count) with a ceiling value of $1,254.54 under a firm fixed-price contract type. This award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The current delivery order for the pain management pharmaceutical reflects the company's role in the DLA Medical Supply Chain and demonstrates its capability to fulfill federal medical supply requirements for controlled pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/31/25 |